Current practices and reform proposals for the regulation of advanced medicinal products in Canada

Written by Regenerative Medicine

Learn more about the current regulatory landscape in Canada and the proposed changes in this review, published in Regenerative Medicine. In this Regenerative Medicine review, the authors describe the Canadian regulatory framework for evaluating advanced medicinal products based on current policies, guidance documents and regulations and analyze proposed reforms. An overview of the Canadian regulatory framework for cell and gene therapy, medical devices and manufacturing facilities is also presented. Viswanathan S, Bubela T. Current practices and reform proposals for the regulation of advanced medicinal products in Canada. Regen. Med. 10(5), 647—663 (2015) Author for correspondance: [email protected]

To view the full article, please register now for access

It's completely free